MedTrace Logo

Intraligmentary Dexamethasone in Lower First Molars With Irreversible Pulpitis and Apical Periodontits

NCT05928611 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2023-07-27

No results posted yet for this study

Summary

Using intraligmentary dexamethasone to reduce the pain intensity during and after root canal preparation

Conditions

  • Pulpitis - Irreversible

Interventions

PROCEDURE

Inferior alveolar nerve block with dexamethasone

Using articaine for inferior alveolar block with intraligmentary dexamethasone

PROCEDURE

Buccal infiltratation with dexamethasone

Using articaine for buccal infiltratation with intraligmentary dexamethasone

PROCEDURE

Inferior alveolar nerve block

Using articaine for injection

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Angie G Ghoneim · Faculty of oral and dental medicine,Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-05-31
Completion
2024-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05928611 on ClinicalTrials.gov